Cancer Detection and Diagnosis Research in Maryland
Cancer Detection and Diagnosis Research (93.394) awarded $103 million to recipients in Maryland in 86 grants from fiscal 2021 to 2025, 3.8% of the program's national total. The Johns Hopkins University received the most, $86.5 million.
- Awarded in Maryland$103 million
- Awards86
- Share of the program3.8%
- Rank among states7th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 48 | $19.5 million |
| FY 2022 | 38 | $17.0 million |
| FY 2023 | 44 | $22.5 million |
| FY 2024 | 43 | $22.2 million |
| FY 2025 | 39 | $21.7 million |
Recipients in Maryland
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Johns Hopkins University | Colleges and universities | 63 | $86.5 million |
| University of Maryland, Baltimore | Colleges and universities | 11 | $12.2 million |
| University of Maryland, College Park | Colleges and universities | 2 | $2.3 million |
| Precyte Inc | Small businesses | 1 | $488,361 |
| Malcova LLC | Small businesses | 1 | $455,000 |
| Oncospace Inc | Small businesses | 1 | $414,358 |
| Trophogen, LLC | Small businesses | 1 | $345,085 |
| Hypermelt, LLC | Small businesses | 1 | $275,721 |
| A&g Pharmaceutical, Inc. | Small businesses | 1 | $112,655 |
| American Society for Investigative Pathology, Inc. | Nonprofits | 3 | $42,500 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 50 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Maryland?
$103 million from fiscal 2021 to 2025, across 86 awards. Maryland ranks 7th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Maryland?
The largest recipient is The Johns Hopkins University, with $86.5 million in 63 awards. Next are University of Maryland, Baltimore and University of Maryland, College Park.
Can organizations in Maryland apply now?
Yes, 50 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Maryland
- Grants to States for Medicaid
- Greenhouse Gas Reduction Fund: National Clean Investment Fund
- Education Stabilization Fund
- Highway Planning and Construction
- USAID Foreign Assistance for Programs Overseas
- 1332 State Innovation Waivers
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies